Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease

Research output: Contribution to journalArticlepeer-review


  • Marian C Brady
  • Christina H Smith
  • Catherine M Sackley

Colleges, School and Institutes


Parkinson's disease patients commonly suffer from speech and vocal problems including dysarthric speech, reduced loudness and loss of articulation. These symptoms increase in frequency and intensity with progression of the disease). Speech and language therapy (SLT) aims to improve the intelligibility of speech with behavioural treatment techniques or instrumental aids.

Bibliographic note

C Smith is listed as C Tomlinson in the article.


Original languageEnglish
Pages (from-to)CD002812
JournalCochrane Database of Systematic Reviews
Publication statusPublished - 15 Aug 2012


  • Dysarthria, Humans, Language Therapy, Parkinson Disease, Randomized Controlled Trials as Topic, Speech Intelligibility, Speech Therapy, Watchful Waiting